Losartan Cost in Missouri 2026: Cash Pay, Medicaid, and Insurance Prices Explained

What Does Losartan Actually Cost in Missouri in 2026?

Generic losartan is one of the least expensive prescription medications available in Missouri. The average cash-pay price across Missouri retail pharmacies in 2026 is approximately $10 per month for a 30-day supply of the most common doses (25 mg, 50 mg, or 100 mg). Merck's originator brand, Cozaar, carries a manufacturer list price of roughly $80 per month, though nearly all patients in Missouri are dispensed the generic.

Losartan potassium is an angiotensin II receptor blocker (ARB) approved by the FDA for hypertension, heart failure with reduced ejection fraction, and diabetic nephropathy in patients with Type 2 diabetes and elevated serum creatinine. The FDA prescribing information for losartan potassium is maintained on the FDA's Access Data portal. Across each of those approved indications, the drug is dosed once daily by mouth, which simplifies adherence and keeps monthly pill counts to 30 tablets.

The $10 cash-pay figure is not guaranteed at every pharmacy. Independent rural Missouri pharmacies, hospital outpatient pharmacies, and specialty compounding pharmacies each set their own pricing. GoodRx and similar discount programs can bring the price at major Missouri chains (Walgreens, CVS, Hy-Vee, Price Chopper) to between $4 and $12 per month depending on the dose. A 90-day supply often drops the per-dose cost further, sometimes to $7 or $8 per month equivalent when purchased at Costco or Sam's Club pharmacies.

Price variation by dose is modest. In Missouri retail pharmacies, the 25 mg, 50 mg, and 100 mg tablets typically cost within a dollar or two of each other on a per-tablet basis, so patients titrated up to 100 mg once daily do not face dramatically higher pharmacy bills than those maintained at 50 mg.

Does Missouri Medicaid Cover Losartan?

Missouri Medicaid (MO HealthNet) covers losartan, but the coverage is restricted to patients whose diagnosis codes indicate Type 2 diabetes. Patients seeking losartan solely for essential hypertension or non-diabetic heart failure may find the drug is not covered under their MO HealthNet plan without a prior authorization tied to a qualifying diagnosis.

This matters practically because losartan is one of the most prescribed antihypertensives in the United States. The Joint National Committee and the American College of Cardiology/American Heart Association 2017 hypertension guidelines recommend ARBs broadly for patients with compelling indications including chronic kidney disease, diabetes, and heart failure with reduced ejection fraction. ACC/AHA hypertension guideline (2017) states: "ARBs are recommended for patients with hypertension and chronic kidney disease to slow kidney disease progression." Missouri Medicaid's narrower T2D-only coverage does not align with the full scope of those recommendations, meaning some Medicaid patients with hypertension-only may need to pursue a prior authorization, appeal, or a covered alternative ARB.

If your MO HealthNet plan denies losartan, the two most commonly covered alternatives in the ARB class on Missouri Medicaid formularies are valsartan and irbesartan. Both are generic and similarly priced. Your prescribing clinician can document a specific clinical indication to support a prior authorization request.

For patients who are dually eligible (Medicare and Medicaid), Medicare Part D formularies almost universally place generic losartan on Tier 1 or Tier 2, typically with a $0 to $5 copay per month. Missouri has approximately 150,000 dual-eligible beneficiaries who may access losartan at little to no cost through the Medicare drug benefit rather than MO HealthNet.

Is Compounded Losartan Legal in Missouri?

Compounded losartan is legal in Missouri when prepared by a state-licensed 503A pharmacy operating within a valid prescriber-patient relationship. Under Section 503A of the Federal Food, Drug, and Cosmetic Act, compounding pharmacies may prepare patient-specific formulations of commercially available drugs, provided the compounded version is not essentially a copy of a commercially available product and that a valid prescription exists. The FDA's 503A guidance is available here.

Missouri's State Board of Pharmacy licenses and inspects 503A facilities within the state. Missouri patients can also receive compounded losartan from out-of-state 503A pharmacies licensed to ship into Missouri, provided those pharmacies hold a Missouri non-resident pharmacy permit.

The cost advantage of compounded losartan can be significant. Some telehealth platforms that operate in Missouri, including HealthRX, bundle compounded losartan into membership programs where the effective out-of-pocket cost to the patient is $0 per month. That $0 figure reflects the membership fee structure absorbing the pharmacy cost rather than the drug itself being free in a traditional insurance sense. Patients should confirm exactly what the membership includes before enrolling.

One practical limit: because commercially available generic losartan tablets are inexpensive and widely available, a 503A pharmacy must be able to document a clinical reason why the compounded version is medically necessary for a specific patient. Common documented reasons include a documented allergy to a tablet excipient (such as a specific dye or filler), the need for a liquid suspension for a patient with swallowing difficulties, or a custom dose not available in commercial tablet form (for example, 37.5 mg for a patient sensitive to standard titration steps).

Missouri does not currently have any 503B outsourcing facilities registered for losartan. 503B facilities produce bulk, non-patient-specific compounded drugs and are subject to FDA current good manufacturing practice (cGMP) standards. All Missouri-compounded losartan is therefore produced at the individual prescription level through 503A pharmacies.

How the LIFE Trial Established Losartan's Clinical Credentials

Understanding why losartan commands attention in Missouri cardiology and nephrology practices requires a brief look at the evidence that shaped prescribing. The Losartan Intervention For Endpoint reduction in hypertension (LIFE) trial, published in The Lancet in 2002, enrolled 9,193 patients with hypertension and electrocardiographic left ventricular hypertrophy and randomized them to losartan-based versus atenolol-based treatment over a mean of 4.8 years. LIFE trial (Lancet 2002, N=9,193)

The primary composite endpoint of cardiovascular death, stroke, or myocardial infarction occurred in 508 patients in the losartan group versus 588 in the atenolol group, representing an 13% relative risk reduction (RR 0.87 to 95% CI 0.77 to 0.98, P=0.021) despite equivalent blood pressure reduction between arms. Stroke reduction drove much of the benefit: 232 strokes occurred in the losartan arm versus 309 in the atenolol arm (RR 0.75 to 95% CI 0.63 to 0.89, P<0.001). That finding positioned losartan as a preferred ARB for patients with hypertension and LVH, a subgroup that comprises roughly 15 to 20 percent of treated hypertensives in the United States.

The LIFE authors wrote: "Losartan prevents more cardiovascular morbidity and death than atenolol for a similar reduction in blood pressure, and is better tolerated." That sentence changed ARB prescribing patterns across cardiology practices and remains the most-cited support for losartan's class differentiation.

For Missouri patients with hypertension plus left ventricular hypertrophy on ECG, losartan's evidence base is stronger than almost any other antihypertensive in that specific phenotype. At $10 per month cash-pay, the cost-effectiveness is among the best available in cardiovascular pharmacology.

Insurance Coverage for Losartan in Missouri: Commercial Plans

Nearly all commercial health insurance plans available in Missouri, including plans sold on the federal Marketplace (healthcare.gov), place generic losartan on Tier 1 or Tier 2 of their formularies. Tier 1 drugs typically carry a $0 to $10 copay per month. Tier 2 drugs typically carry a $10 to $40 copay per month.

Missouri's largest commercial insurance carriers include Anthem (BlueCross BlueShield of Missouri), Cigna, Aetna, and United Healthcare. All four list generic losartan as a preferred generic on their standard formularies as of 2026. Patients whose plans have a deductible phase may pay the full cash price (approximately $10 to $15) during the deductible period, then switch to a flat copay once the deductible is met.

Self-insured employer plans in Missouri follow the same general pattern. Missouri's large employers, including Boeing, Centene, Edward Jones, and the state government itself, all use pharmacy benefit managers (Express Scripts or CVS Caremark) that place generic losartan on Tier 1.

One nuance affects some Missouri patients: high-deductible health plans (HDHPs) paired with health savings accounts (HSAs) require the deductible to be met before drug coverage activates for non-preventive medications. At $10 per month cash-pay, this rarely creates a financial barrier. But patients on high-dose losartan (100 mg) plus a combination product (such as losartan/hydrochlorothiazide) should be aware that the combination tablet carries a slightly higher cash price, typically $15 to $25 per month.

What's the Cheapest Way to Get Losartan in Missouri?

The cheapest realistic path to losartan in Missouri in 2026 depends on your insurance status and clinical picture. Three tiers of cost exist.

Tier 1: $0/month. Patients enrolled in a telehealth membership program that bundles compounded losartan, or patients on Medicare Part D with low-income subsidy (LIS, also called "Extra Help"), may pay nothing at the pharmacy counter. The Medicare Low Income Subsidy program covers nearly all generic drugs at $0 to $4.50 for full-subsidy beneficiaries. CMS Low Income Subsidy program covers approximately 13 million Medicare beneficiaries nationally.

Tier 2: $4 to $12/month. Cash-paying Missouri patients without insurance, or those in the deductible phase of an HDHP, can use GoodRx, RxSaver, NeedyMeds, or manufacturer savings cards at participating Missouri pharmacies. The GoodRx price for generic losartan 50 mg (30 tablets) at Kansas City-area and St. Louis-area pharmacies as of early 2026 ranges from approximately $4 to $8. Walmart's $4 generic drug program includes losartan potassium in select doses at qualifying Missouri Walmart pharmacy locations.

Tier 3: $10 to $15/month. Standard cash-pay at a Missouri retail pharmacy without any discount program applied. This is still inexpensive by any measure, but applying a free discount card takes about 30 seconds and can cut the price in half.

The HealthRX Missouri Losartan Cost Decision Framework works as follows. First, check your insurance formulary tier. If Tier 1 with a $0 copay, use your insurance. If Tier 2 or higher, compare against GoodRx at your specific Missouri zip code pharmacy because the cash-pay or discount price may be lower than your copay. Second, if you lack insurance, check the Walmart $4 generic list before applying any third-party discount card, since Walmart's internal price may beat third-party programs. Third, if you have a specific documented clinical reason for a compounded formulation (excipient allergy, swallowing difficulty, or non-standard dose), ask your HealthRX clinician whether a 503A compounded losartan prescription is appropriate for your case.

Missouri Losartan Discount Programs: What Actually Works

Several discount mechanisms operate in Missouri and deserve specific mention.

GoodRx and RxSaver. Both are free to use and accepted at the major Missouri pharmacy chains. Present the coupon code at the pharmacy counter instead of your insurance card during any deductible phase. In 2026 the GoodRx price for losartan 50 mg at St. Louis-area pharmacies has been running between $4 and $9 depending on the specific location.

NeedyMeds. A nonprofit that maintains discount cards and a database of patient assistance programs. NeedyMeds lists multiple programs for Missouri patients who are uninsured or underinsured.

Merck Patient Assistance. Merck's patient assistance program (Merck Helps) provides brand-name Cozaar at no charge to qualifying uninsured patients meeting income thresholds. For most Missouri patients, however, the generic is so inexpensive that brand-name assistance offers no practical advantage.

Missouri Rx Plan. Missouri discontinued its state-run Rx program years ago, so there is no active state pharmaceutical assistance program as of 2026. Missouri seniors who do not qualify for Medicare Part D Low Income Subsidy should use a Medicare Extra Help application through the Social Security Administration rather than a state program.

Missouri Rx Reimbursement through Federally Qualified Health Centers (FQHCs). Missouri FQHCs participate in the 340B drug pricing program, which allows them to dispense covered outpatient drugs including losartan at significantly reduced prices to eligible low-income patients. The 340B price for generic losartan is typically below $5 per month. Missouri has more than 60 FQHC sites across the state, including in rural areas of the Ozarks and Bootheel regions where pharmacy access can be limited.

Can I Get Losartan via Telehealth in Missouri?

Telehealth prescribing of losartan in Missouri is fully legal and widely practiced in 2026. Missouri follows the Ryan Haight Act's rules for controlled substances, but losartan is not a controlled substance, so it faces no telemedicine-specific prescribing restrictions beyond the general requirement for a valid prescriber-patient relationship. Missouri State Board of Registration for the Healing Arts requires that telehealth prescribing establish a clinical relationship that meets the same standard of care as in-person care.

Practically, a telehealth encounter for losartan initiation in Missouri typically involves a brief asynchronous or synchronous visit where the clinician reviews blood pressure readings (often submitted by the patient from a home cuff), a brief history, any contraindications (bilateral renal artery stenosis, pregnancy, hyperkalemia), and current medications. The initial visit takes 10 to 20 minutes. Refills can often be handled asynchronously.

Patients starting losartan via telehealth should have a home blood pressure monitor. The American Heart Association recommends upper-arm oscillometric monitors validated under the AAMI/ISO standard. Most cost between $25 and $50 on Amazon. Consistent measurement technique matters more than the specific device brand.

One contraindication Missouri telehealth clinicians screen carefully for is pregnancy. Losartan is Pregnancy Category D and carries a black-box warning: exposure during the second and third trimesters causes fetal renal dysplasia, oligohydramnios, and neonatal renal failure. FDA labeling for losartan Any woman of reproductive age who could become pregnant must be counseled on reliable contraception before losartan is prescribed, whether in-person or via telehealth.

A typical Missouri telehealth losartan workflow: 15-minute initial visit, prescription sent electronically to the patient's preferred Missouri pharmacy, baseline labs (basic metabolic panel to check potassium and creatinine) within 2 to 4 weeks, follow-up blood pressure check at 4 to 6 weeks, and annual lab monitoring thereafter.

Monitoring Requirements That Affect Your Total Losartan Cost in Missouri

The drug itself is inexpensive, but patients sometimes underestimate the monitoring costs that accompany any ARB prescription. Missouri clinicians generally order:

• A baseline basic metabolic panel (BMP) before starting losartan to establish creatinine and potassium levels.
• A repeat BMP at 2 to 4 weeks after initiation or any dose change to screen for hyperkalemia (potassium above 5.5 mEq/L) and worsening renal function.
• Annual BMP and urine albumin-to-creatinine ratio (uACR) for patients with chronic kidney disease or diabetes.

A BMP at a Missouri commercial lab (Quest or LabCorp) costs approximately $15 to $35 cash-pay without insurance, or $0 to $15 with standard commercial insurance after the deductible. Missouri Medicaid covers BMP and uACR without prior authorization for patients on antihypertensive therapy.

The kidney-protective benefit of losartan in diabetic nephropathy was established in the RENAAL trial (N=1,513), where losartan 50 to 100 mg daily reduced the composite of doubling of serum creatinine, end-stage renal disease, or death by 16% relative to placebo over a mean of 3.4 years (RR 0.84 to 95% CI 0.72 to 0.98, P=0.02). RENAAL trial For Missouri patients with Type 2 diabetes and proteinuria, the clinical value of that 16% risk reduction over 3.4 years far outweighs a $10/month drug cost.